Résumé
The hepatic conversion of cholesterol to bile acids is an important mechanism for the elimination of excess dietary cholesterol. Bile acid biosynthesis and transport are regulated by the farnesoid X receptor (FXR), a member of the of nuclear hormone receptor gene superfamily. Thus, therapeutic strategies that target FXR represent a promising new approach for the treatment of hypercholesterolemia. Recent studies have provided new evidence in support of the potential for FXR ligands as antihypercholesterolemic agents.
Langue d'origine | English |
---|---|
Pages (de-à) | 275-276 |
Nombre de pages | 2 |
Journal | Trends in Endocrinology and Metabolism |
Volume | 13 |
Numéro de publication | 7 |
DOI | |
Statut de publication | Published - sept. 2002 |
ASJC Scopus Subject Areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
PubMed: MeSH publication types
- News